Pharmacology
15 articles on Pharmacology, written by Shotlee and medically reviewed for clinical accuracy.
Retatrutide: A New Era in Weight Loss Drugs vs. Ozempic
Eli Lilly's experimental drug retatrutide has demonstrated unprecedented weight loss results in a pivotal trial. This article delves into its mechanisms, efficacy, safety, and how it stacks up against current leading weight loss medications like Ozempic and Wegovy.
6 min read
GLP-1 Agonists: A New Frontier in Liver Disease Treatment
GLP-1 receptor agonists, renowned for their impact on type 2 diabetes and obesity, are now emerging as powerful allies in the fight against liver diseases like MASH and alcohol-associated liver disease. Discover how these groundbreaking medications are reshaping hepatology.
6 min read
Generic Ozempic® Now Available in Canada: What You Need to Know
Apotex Inc. has launched Apo-Semaglutide Injection™, a generic version of Ozempic®, in Canada. This development brings a more affordable treatment option for type 2 diabetes management to Canadian patients and healthcare providers.
6 min read
GLP-1 Weight Loss Drugs: Usage Trends and What You Need to Know
The popularity of GLP-1 receptor agonists for weight management is soaring. This article delves into the latest trends, the science behind these medications, and essential considerations for patients and healthcare providers.
7 min read
GLP-1 Weight Loss Drugs: Why Eating Habits Matter for Success
New research suggests that the way you eat—whether driven by emotions or external cues—can significantly influence how well GLP-1 medications like Ozempic, Wegovy, and Mounjaro work for weight loss and type 2 diabetes management. Learn what this means for your treatment.
7 min read
GLP-1 Drugs: New Insights into How They Suppress Cravings
A groundbreaking NIH-funded study reveals that emerging GLP-1 weight-loss drugs, including oral options like orforglipron, work by targeting a specific brain reward pathway, distinct from their appetite-suppressing effects. This discovery opens new avenues for understanding and treating conditions beyond weight management.
6 min read
GLP-1 Medications: Understanding Drug Interactions and Safety
GLP-1 receptor agonists are powerful tools for managing diabetes and obesity, but understanding their potential interactions with other medications is crucial for patient safety and treatment efficacy.
7 min read
Unexpected Discoveries: How Failed Drugs Became Medical Breakthroughs
Discover how serendipity and keen observation transformed drug development, leading to life-changing treatments for conditions ranging from diabetes and obesity to erectile dysfunction and wrinkles.
6 min read
Medicaid GLP-1 Coverage Changes: Access to Ozempic and Wegovy
A growing number of state Medicaid programs are restricting or eliminating coverage for GLP-1 medications like Ozempic and Wegovy for obesity treatment due to budget constraints.
8 min read
GLP-1 Drugs: New Hope for Depression and Motivation?
A recent study published in JAMA Psychiatry has unveiled promising findings regarding GLP-1 receptor agonists, such as semaglutide, and their potential to address a core symptom of major depressive disorder: a lack of motivation. This article delves into the study's methodology, results, and the broader implications for mental health treatment.
8 min read
Eli Lilly's Oral GLP-1: A Strong Start Amidst Weight Loss Drug Hype
Eli Lilly's groundbreaking oral GLP-1, Foundayo, is demonstrating a promising launch, exceeding initial expectations and hinting at a significant expansion of the weight loss and diabetes management market. Discover the latest insights and what it means for patients and the industry.
7 min read
GLP-1s and Pregnancy: New Study Offers Cautious Reassurance
New research from the University of St Andrews offers a glimmer of hope for individuals using GLP-1 medications who become pregnant. This comprehensive review of nearly 50,000 pregnancies suggests a potentially lower risk of adverse outcomes than previously feared, though experts emphasize caution.
7 min read
Orforglipron: The New Oral GLP-1 Challenger in Weight Loss
A new daily pill, Orforglipron, is emerging as a significant contender in the weight loss and diabetes management space, offering a potential oral alternative to injectable GLP-1 medications. This article delves into its mechanisms, trial results, and what it means for the future of treatment.
7 min read
Your Gut's Natural Weight Loss System: The Science Behind GLP-1 Hormones
Discover the fascinating connection between your gut microbiome, the food you eat, and the natural hormones that regulate appetite and metabolism. Learn how these internal systems are similar to groundbreaking weight loss medications like Ozempic, Wegovy, and Mounjaro.
7 min read
Tirzepatide Plateaus: Understanding 'Plateau Panic' and What Comes Next
Many individuals experience remarkable initial success with Tirzepatide, only to find their progress unexpectedly stalling. This phenomenon, known as 'Plateau Panic,' is a growing concern. This article delves into why these plateaus occur, what they signify, and the advanced strategies available to help you regain momentum.
8 min read